RU2004131822A - Амиды пиперазинил- или пиперидиниламинсульфаминовой кислоты в качестве ингибиторов стероидной сульфатазы - Google Patents
Амиды пиперазинил- или пиперидиниламинсульфаминовой кислоты в качестве ингибиторов стероидной сульфатазы Download PDFInfo
- Publication number
- RU2004131822A RU2004131822A RU2004131822/04A RU2004131822A RU2004131822A RU 2004131822 A RU2004131822 A RU 2004131822A RU 2004131822/04 A RU2004131822/04 A RU 2004131822/04A RU 2004131822 A RU2004131822 A RU 2004131822A RU 2004131822 A RU2004131822 A RU 2004131822A
- Authority
- RU
- Russia
- Prior art keywords
- hydrogen
- compound according
- chloro
- formula
- tert
- Prior art date
Links
- 229940123142 Steroid sulfatase inhibitor Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 239000001257 hydrogen Substances 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 9
- 125000001309 chloro group Chemical group Cl* 0.000 claims 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 claims 2
- 108010087999 Steryl-Sulfatase Proteins 0.000 claims 2
- 102100038021 Steryl-sulfatase Human genes 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Claims (10)
1. Соединение формулы
в которой R1 и R2 совместно с атомом азота, к которому они присоединены, обозначают 6-членный алифатический гетероциклил, содержащий один или два атома азота в качестве гетероатомов;
или
R1 обозначает водород, a R2 обозначает группу формулы
в которой R9 обозначает (С1-С8)алкоксикарбонил или незамещенный или замещенный фенил; и
R3 обозначает (С6-С18)арил или (С6-С18)арил(С1-С4)алкил.
3. Соединение по п.1, представленное формулой
в которой R обозначает COOR’, n равно 0 и
R’ обозначает трет-бутил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают CF3;
R’ обозначает трет-бутил, R6, R7 и R8 обозначают водород и R4 и R5 обозначают хлор;
R’ обозначает трет-бутил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают хлор;
R’ обозначает фенилметил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают CF3;
R’ обозначает фенилметил, R6, R7 и R8 обозначают водород и R4 и R5 обозначают хлор; или
R’ обозначает фенилметил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают хлор;
или
R обозначает COOR’, n равно 2 и
R’ обозначает трет-бутил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают трифторметил;
или
R обозначает пара-трифтор-, орто-аминокарбонилфенил, R4, R6 и R8 обозначают водород и R5 и R7 обозначают трифторметил, n равно 0;
R обозначает пара-трифтор-, орто-аминокарбонилфенил, R4, R6 и R8 обозначают водород R5 и R7 обозначают хлор, n равно 0;
R обозначает пара-трифтор-, орто-аминокарбонилфенил, R4, R5 и R6 обозначают водород R7 и R8 обозначают хлор, n равно 0.
5. Соединение по п.1 в форме соли.
6. Применение амида сульфаминовой кислоты в качестве ингибитора стероидной сульфотазы.
7. Способ профилактики или лечения расстройств, опосредованных действием стероидной сульфатазы, заключающийся во введении субъекту, нуждающемуся в подобном лечении, эффективного количества соединения по п.1.
8. Фармацевтическая композиция, включающая по меньшей мере одно соединение по п.1 в сочетании с фармацевтическим наполнителем.
9. Соединение по п.1 для применения в качестве фармацевтического препарата.
10. Соединение по п.1 для применения в приготовлении лекарственного средства для профилактики или лечения расстройств, опосредованных действием стероидной сульфатазы.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0207500A GB0207500D0 (en) | 2002-03-28 | 2002-03-28 | Organic compounds |
GB0207500.0 | 2002-03-28 | ||
GB0225679A GB0225679D0 (en) | 2002-11-04 | 2002-11-04 | Organic compounds |
GB0225679.0 | 2002-11-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2004131822A true RU2004131822A (ru) | 2005-07-10 |
RU2329258C2 RU2329258C2 (ru) | 2008-07-20 |
Family
ID=28676499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2004131822/04A RU2329258C2 (ru) | 2002-03-28 | 2003-03-27 | Амиды пиперазинил- или пиперидиниламинсульфаминовой кислоты и их применение в качестве ингибиторов стероидной сульфатазы |
Country Status (20)
Country | Link |
---|---|
US (2) | US7439362B2 (ru) |
EP (1) | EP1492782A1 (ru) |
JP (1) | JP4580652B2 (ru) |
KR (1) | KR20040094877A (ru) |
CN (1) | CN1293065C (ru) |
AR (1) | AR039156A1 (ru) |
AU (1) | AU2003226732B2 (ru) |
BR (1) | BR0308795A (ru) |
CA (1) | CA2480686A1 (ru) |
CO (1) | CO5640113A2 (ru) |
IL (1) | IL164267A0 (ru) |
MX (1) | MXPA04009453A (ru) |
MY (1) | MY136880A (ru) |
NO (1) | NO20044321L (ru) |
NZ (1) | NZ535617A (ru) |
PE (1) | PE20040167A1 (ru) |
PL (1) | PL372602A1 (ru) |
RU (1) | RU2329258C2 (ru) |
TW (1) | TW200306806A (ru) |
WO (1) | WO2003082842A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0505539D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0511190D0 (en) * | 2005-06-01 | 2005-07-06 | Sterix Ltd | Use |
JP5543920B2 (ja) | 2007-09-17 | 2014-07-09 | プレグレム エスアー | 閉経前の女性におけるエストロゲン依存症状の治療 |
US11338043B2 (en) | 2016-02-08 | 2022-05-24 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugates |
US10874746B2 (en) | 2016-02-08 | 2020-12-29 | Synaffix B.V. | Sulfamide linkers for use in bioconjugates |
CN109152844B (zh) * | 2016-02-08 | 2022-11-22 | 西纳福克斯股份有限公司 | 用于治疗的含有磺酰胺接头的生物缀合物 |
EP3548480A1 (en) * | 2016-11-29 | 2019-10-09 | Epizyme, Inc. | Compounds containing a sulfonic group as kat inhibitors |
EP3983388A1 (en) * | 2019-06-12 | 2022-04-20 | Nodthera Limited | Sulfonamide derivatives and uses thereof |
CN110590896B (zh) * | 2019-11-04 | 2022-08-30 | 上海高准医药有限公司 | 雌酚酮硫酸酯哌嗪的制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US89089A (en) * | 1869-04-20 | Improved car-coupling | ||
US478328A (en) * | 1892-07-05 | Glass-heating oven | ||
US71516A (en) * | 1867-11-26 | William b | ||
US183459A (en) * | 1876-10-17 | Improvement in hinges | ||
US51547A (en) * | 1865-12-19 | Improvement in guide and tuck-marker for sewing-machines | ||
US876846A (en) * | 1907-05-28 | 1908-01-14 | Stephen W Smith | Road-machine. |
US1122242A (en) * | 1912-05-13 | 1914-12-29 | Sanitary Can Company | Can-body-feeding device. |
US2103610A (en) * | 1935-04-30 | 1937-12-28 | Sofal Ltd | Alloy steels |
DE876846C (de) * | 1943-06-01 | 1953-05-18 | Bayer Ag | Verfahren zur Herstellung von Abkoemmlingen des Sulfondiamids |
US3004487A (en) * | 1959-12-07 | 1961-10-17 | Bank Of America Nat Trust & Savings Ass | Imprinters |
GB1593609A (en) * | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
FR2510106A1 (fr) | 1981-07-27 | 1983-01-28 | Rhone Poulenc Agrochimie | Composes herbicides derives d'acides phenoxybenzoiques, et leurs procedes de preparation et d'utilisation |
DK101683A (da) * | 1982-03-12 | 1983-09-13 | Duphar Int Res | Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf |
US5238923A (en) * | 1989-05-26 | 1993-08-24 | Warner-Lambert Company | Amino-substituted heterocycles as renin inhibitors |
US5256632A (en) * | 1990-05-30 | 1993-10-26 | Bayer Aktiengesellschaft | Herbicidal sulphonylated carboxamides |
IL99537A (en) | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
US5464788A (en) | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
US5783582A (en) | 1994-07-20 | 1998-07-21 | Merck & Co., Inc. | Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone |
CA2200981A1 (en) | 1994-10-04 | 1996-04-11 | Hisashi Takasugi | Urea derivatives and their use as acat-inhibitors |
AU7626496A (en) | 1995-12-01 | 1997-06-27 | Ciba-Geigy Ag | Heteroaryl compounds |
DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621482A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
AU6896298A (en) | 1997-04-14 | 1998-11-11 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
US6673799B1 (en) | 1998-09-22 | 2004-01-06 | Yamanouchi Pharmaceutical Co. Ltd. | Cyanophenyl derivative |
US6335343B1 (en) | 1999-03-03 | 2002-01-01 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
EP1185512A2 (en) | 1999-05-24 | 2002-03-13 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
JP4320089B2 (ja) * | 1999-07-06 | 2009-08-26 | あすか製薬株式会社 | フェニルスルファメート誘導体 |
US6632815B2 (en) * | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
SI1226127T1 (sl) | 2000-05-04 | 2009-10-31 | Basf Se | Substituirani fenilsulfamoil karboksamidi |
BR0210391A (pt) * | 2001-06-12 | 2004-06-15 | Elan Pharm Inc | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto |
BR0210733A (pt) | 2001-07-02 | 2004-07-20 | Astrazeneca Ab | Derivados de piperidina de utilidade úteis como moduladores da atividade do receptor de quimocina |
-
2003
- 2003-03-26 PE PE2003000308A patent/PE20040167A1/es not_active Application Discontinuation
- 2003-03-26 AR ARP030101062A patent/AR039156A1/es unknown
- 2003-03-27 US US10/509,259 patent/US7439362B2/en not_active Expired - Fee Related
- 2003-03-27 RU RU2004131822/04A patent/RU2329258C2/ru not_active IP Right Cessation
- 2003-03-27 NZ NZ535617A patent/NZ535617A/en unknown
- 2003-03-27 MX MXPA04009453A patent/MXPA04009453A/es active IP Right Grant
- 2003-03-27 CN CNB038083361A patent/CN1293065C/zh not_active Expired - Fee Related
- 2003-03-27 EP EP03745281A patent/EP1492782A1/en not_active Withdrawn
- 2003-03-27 TW TW092106942A patent/TW200306806A/zh unknown
- 2003-03-27 KR KR10-2004-7015312A patent/KR20040094877A/ko not_active Application Discontinuation
- 2003-03-27 PL PL03372602A patent/PL372602A1/xx unknown
- 2003-03-27 IL IL16426703A patent/IL164267A0/xx unknown
- 2003-03-27 WO PCT/EP2003/003214 patent/WO2003082842A1/en active Application Filing
- 2003-03-27 JP JP2003580309A patent/JP4580652B2/ja not_active Expired - Fee Related
- 2003-03-27 AU AU2003226732A patent/AU2003226732B2/en not_active Ceased
- 2003-03-27 BR BR0308795-6A patent/BR0308795A/pt not_active IP Right Cessation
- 2003-03-27 CA CA002480686A patent/CA2480686A1/en not_active Abandoned
- 2003-03-28 MY MYPI20031151A patent/MY136880A/en unknown
-
2004
- 2004-09-28 CO CO04096497A patent/CO5640113A2/es unknown
- 2004-10-12 NO NO20044321A patent/NO20044321L/no not_active Application Discontinuation
-
2008
- 2008-09-16 US US12/211,525 patent/US20090042899A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MY136880A (en) | 2008-11-28 |
AU2003226732B2 (en) | 2006-12-21 |
CO5640113A2 (es) | 2006-05-31 |
AR039156A1 (es) | 2005-02-09 |
IL164267A0 (en) | 2005-12-18 |
PE20040167A1 (es) | 2004-05-26 |
CN1646509A (zh) | 2005-07-27 |
WO2003082842A1 (en) | 2003-10-09 |
RU2329258C2 (ru) | 2008-07-20 |
US7439362B2 (en) | 2008-10-21 |
EP1492782A1 (en) | 2005-01-05 |
MXPA04009453A (es) | 2005-01-25 |
JP4580652B2 (ja) | 2010-11-17 |
KR20040094877A (ko) | 2004-11-10 |
NO20044321L (no) | 2004-10-12 |
US20060052393A1 (en) | 2006-03-09 |
CA2480686A1 (en) | 2003-10-09 |
PL372602A1 (en) | 2005-07-25 |
US20090042899A1 (en) | 2009-02-12 |
CN1293065C (zh) | 2007-01-03 |
JP2005526812A (ja) | 2005-09-08 |
AU2003226732A1 (en) | 2003-10-13 |
NZ535617A (en) | 2006-04-28 |
TW200306806A (en) | 2003-12-01 |
BR0308795A (pt) | 2005-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
HRP20050663A2 (en) | Malonamide derivatives as gamma-secretase inhibitors | |
RU2203887C2 (ru) | Циклические аминопроизводные, фармацевтическая композиция и способ профилактики заболевания | |
RU2401658C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
EA200900358A1 (ru) | Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv | |
RU2008129723A (ru) | Ингибиторы ccr9 активности | |
RU2007134380A (ru) | Антибактериальные производные пиперидина | |
JP2004523581A5 (ru) | ||
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
EA200400073A1 (ru) | Пирролопиримидины как ингибиторы протеинкиназы | |
TW200614983A (en) | 5-substituted-2-phenylamino benzamides as MEK inhibitors | |
JP2005536475A5 (ru) | ||
MY143568A (en) | 11b-hsd1 inhibitors for the treatment of diabetes | |
RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
RU2004131822A (ru) | Амиды пиперазинил- или пиперидиниламинсульфаминовой кислоты в качестве ингибиторов стероидной сульфатазы | |
EA200500096A1 (ru) | Гетеробиарильные производные в качестве ингибиторов матриксных металлопротеиназ | |
RU2008129635A (ru) | Ингибиторы ссr9 активности | |
DK1750703T3 (da) | Fremgangsmåde til at reducere gastrointestinal toksitet forårsaget af indgivelsen af tegafur | |
TN2009000452A1 (en) | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof | |
RU2008129623A (ru) | Ингибиторы ccr9 активности | |
JP2014517848A5 (ru) | ||
AR057570A1 (es) | Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o | |
EA200500683A1 (ru) | Новые соединения пирролидина и тиазолидина, способ их получения и фармацевтические композиции, которые их содержат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110328 |